From the baseline to end of trial for 18 weeks, mean diastolic BP dropped by 1.9 mmHg and systolic BP declined more prominently by 2.9 mmHg accompanied by a decreasing trend in hypertension prevalence from 86% to 68% in the experimental group.
← all excerpts
The Bioprotective Effects of Polyphenols on Metabolic Syndrome against Oxidative Stress: Evidences and Perspectives.
1
—
—